性别差异在降胸主动脉瘤管理中的系统综述与荟萃分析
该系统综述与荟萃分析评估了完整退行性降胸主动脉瘤修复后30天死亡率、住院时间和不良神经事件的性别差异。TEVAR术后女性30天死亡率显著高于男性(5% vs 3%,OR 1.75),住院时间更长,卒中率无差异;开放修复仅一项研究显示男女30天死亡率相似。
要点
- TEVAR术后女性30天死亡率高于男性(5% vs 3%,OR 1.75,95%CI 1.29-2.38)。
- 女性TEVAR术后住院时间更长(标准化均数差0.3天,95%CI 0.14-0.47)。
- 开放修复仅一项全国性研究显示男女30天死亡率相似,但证据不足。
核心结论
- 在完整退行性降胸主动脉瘤的管理中,TEVAR术后女性30天死亡率明显高于男性,且未确定差异原因。
- 开放修复的当代证据缺乏,因近期数据不足。
研究设计与样本
- 系统综述与荟萃分析,检索MEDLINE、Embase和CENTRAL数据库2005至2019年文献。
- TEVAR分析纳入7项研究,共2758名女性和4674名男性;其中6项研究(1756名女性,2619名男性)符合主要结局分析。
- 开放修复仅识别到一项具有全国覆盖范围的研究。
主要发现
- TEVAR术后30天死亡率:女性5%(95%CI 3-7),男性3%(95%CI 2-4),OR 1.75(95%CI 1.29-2.38)。
- TEVAR术后住院时间女性更长,标准化均数差0.3天(95%CI 0.14-0.47;6项研究)。
- TEVAR术后卒中率在两性间无差异。
- 开放修复的单一研究显示男女30天死亡率相似。
关键数值与推荐
- TEVAR术后30天死亡率女性5%(95%CI 3-7),男性3%(95%CI 2-4),OR 1.75(95%CI 1.29-2.38)。
- 住院时间标准化均数差0.3天(95%CI 0.14-0.47),女性更长。
临床怎么用
- 临床决策时应考虑TEVAR术后女性30天死亡率较高的风险。
- 对于女性降胸主动脉瘤患者,需权衡TEVAR与开放修复的获益风险。
局限性
- 开放修复的当代证据缺乏,仅基于一项研究。
- 未确定TEVAR术后性别差异的原因。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To assess sex specific differences in 30 day mortality, length of hospital stay, and adverse neurological events following repair of intact degenerative descending thoracic aortic aneurysms (TAAs), by either thoracic endovascular (TEVAR) or open repair. METHODS: MEDLINE, Embase, and CENTRAL databases were searched from 2005 to 2019, using ProQuest Dialog. The reviews were registered in PROSPERO (CRD42017020026) and performed according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. The primary outcome was 30 day mortality; secondary outcomes were length of hospital stay and adverse neurological events. Forest plots with random effects meta-analysis to provide odds ratios (OR) were used for primary assessment. RESULTS: For TEVAR, seven studies were identified, including 2758 women and 4674 men; of these studies six were eligible for the primary outcome of 30 day mortality, including 1756 women and 2619 men. There were 94/1756 deaths in women and 82/2619 deaths in men, yielding a pooled 30 day mortality of 5% (95% confidence interval [CI] 3-7) in women and 3% (95% CI 2-4) in men (OR 1.75, 95% CI 1.29-2.38). Length of hospital stay was longer in women, with a standardised mean difference of 0.3 days (95% CI 0.14-0.47; six studies): meta-regression analysis did not identify the slightly older age of women as significant factor in these differences. Stroke rate was not different between the sexes. For open repair only a single study, with national coverage, was identified: this study reported similar 30 day mortality in men and women. CONCLUSIONS: In the management of intact degenerative descending TAAs, 30 day mortality after TEVAR appears to be much higher in women than men with no reasons for this difference identified. However, for open repair there is a lack of contemporary evidence owing to insufficient recent data.
引用
- Ulug P, Powell JT, Warschkow R, et al. Editor's Choice - Sex Specific Differences in the Management of Descending Thoracic Aortic Aneurysms: Systematic Review with Meta-Analysis. Eur J Vasc Endovasc Surg. 2019. PMID: 31371067. doi:10.1016/j.ejvs.2019.04.022
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。